Structures by: Oliveira M. A.
Total: 10
Aripiprazole; 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril
C23H27Cl2N3O2
CrystEngComm (2016) 18, 9 1486
a=16.6133(10)Å b=6.9533(4)Å c=19.4632(11)Å
α=90° β=106.9900(10)° γ=90°
Aripiprazole 1-propanol solvate; 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril 1-propanol solvate
C23H27ClN3O20.5(C3H8O)
CrystEngComm (2016) 18, 9 1486
a=7.7282(6)Å b=10.7005(8)Å c=15.4954(12)Å
α=83.8630(10)° β=78.1910(10)° γ=73.5760(10)°
Dihydrocarbamazepine saccharin
C15H14N2O,C7H5NO3S
Crystal Growth & Design (2011) 11, 2 449
a=7.5822(12)Å b=25.215(6)Å c=10.554(3)Å
α=90.00° β=105.878(8)° γ=90.00°
Cyheptamide saccharin
C16H15NO,C7H5NO3S
Crystal Growth & Design (2011) 11, 2 449
a=7.7883(3)Å b=24.7090(9)Å c=10.5827(4)Å
α=90.00° β=106.951(2)° γ=90.00°
C23H25Cl2N3O2
C23H25Cl2N3O2
Crystal Growth & Design (2013) 13, 5 2036
a=7.7801(3)Å b=6.7905(2)Å c=40.5837(16)Å
α=90.00° β=95.328(3)° γ=90.00°
C23H25Cl2N3O2
C23H25Cl2N3O2
Crystal Growth & Design (2013) 13, 5 2036
a=13.8150(3)Å b=9.1160(2)Å c=17.5978(3)Å
α=90.00° β=102.7950(10)° γ=90.00°
C23H25Cl2N3O2
C23H25Cl2N3O2
Crystal Growth & Design (2013) 13, 5 2036
a=16.3186(3)Å b=7.05320(10)Å c=19.1212(3)Å
α=90.00° β=105.8940(10)° γ=90.00°
C23H27Cl2N3O3
C23H27Cl2N3O3
Crystal Growth & Design (2013) 13, 5 2036
a=11.1026(14)Å b=12.6790(14)Å c=16.6841(19)Å
α=90.00° β=97.475(8)° γ=90.00°
[C23H25Cl2N3O2],0.8[CH4O]
[C23H25Cl2N3O2],0.8[CH4O]
Crystal Growth & Design (2013) 13, 5 2036
a=7.6794(2)Å b=8.1951(2)Å c=19.2697(4)Å
α=85.791(2)° β=88.984(2)° γ=75.052(2)°
C24H29Cl2N3O3
C24H29Cl2N3O3
Crystal Growth & Design (2013) 13, 5 2036
a=8.3321(7)Å b=10.1219(8)Å c=15.1680(13)Å
α=84.562(5)° β=84.704(5)° γ=68.879(4)°